Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Long-term improvement of urinary incontinence achieved with solifenacin

Sep. 2, 2004

Novel 17beta-HSD-3 inhibitors and their use claimed by Schering-Plough

Sep. 2, 2004

Cannabinoids found to improve urge incontinence in MS patients

Sep. 2, 2004

Good safety profile reported for darifenacin in OAB

Sep. 2, 2004

New selective beta3-adrenoceptor agonist in development at Mitsubishi

Aug. 31, 2004

Fesoterodine reduces micturition and urge incontinence in UFS

Aug. 31, 2004

Extended-release tolterodine shows efficacy for mixed incontinence in women

Aug. 31, 2004

Yamanouchi to roll out Vesicare in E.U.

Aug. 30, 2004

Orally active nonpeptide aquaretic V2 antagonist advanced to human testing

Aug. 25, 2004

Yamanouchi and Boehringer Ingelheim to copromote Flomax in U.S. for BPH

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...